Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × Educational Status × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 8 Breast Neoplasms 7 Lung Neoplasms 6 Prostatic Neoplasms 4 Obesity-Related Malignant Neoplasm 3 Neoplasm Metastasis 3 Lymphoma 3 Hematopoietic and Lymphatic System Neoplasm 3 Triple Negative Breast Neoplasms 2 Skin Carcinoma 2 Papillomavirus Infections 2 Hematologic Neoplasms 2 Anatomic Stage I Breast Cancer AJCC v8 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Testicular Neoplasms 1 Substance-Related Disorders 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Opioid-Related Disorders 1 Neoplasms 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Glioblastoma 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1

Interventions

venetoclax 42 Rituximab 25 obinutuzumab 22 ibrutinib 22 Cyclophosphamide 22 acalabrutinib 19 pirtobrutinib 17 fludarabine 17 Specimen Handling 11 zanubrutinib 10 fludarabine phosphate 10 Biopsy 10 Bendamustine Hydrochloride 10 Magnetic Resonance Spectroscopy 7 Whole-Body Irradiation 5 Prednisone 5 Lenalidomide 5 idelalisib 4 Vincristine 4 Mycophenolic Acid 4 Doxorubicin 4 CT-P10 4 ARQ531 4 pembrolizumab 3 Tacrolimus 3 tocilizumab 2 duvelisib 2 daratumumab 2 atezolizumab 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡